Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer.
Saved in:
| Title: | Immune-Related Adverse Events, Biomarkers of Systemic Inflammation, and Survival Outcomes in Patients Receiving Pembrolizumab for Non-Small-Cell Lung Cancer. |
|---|---|
| Authors: | Raynes, George1 (AUTHOR), Stares, Mark1,2 (AUTHOR) mark.stares@ed.ac.uk, Low, Samantha1 (AUTHOR), Haron, Dhania1 (AUTHOR), Sarwar, Hussain1 (AUTHOR), Abhi, Dhruv1 (AUTHOR), Barrie, Colin1 (AUTHOR), Laird, Barry2 (AUTHOR), Phillips, Iain1,2 (AUTHOR), MacKean, Melanie1 (AUTHOR) |
| Source: | Cancers. Dec2023, Vol. 15 Issue 23, p5502. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers15235502 |
